These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17437847)
1. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells. Anai S; Tanaka M; Shiverick KT; Kim W; Takada S; Boehlein S; Goodison S; Mizokami A; Rosser CJ J Urol; 2007 May; 177(5):1913-7. PubMed ID: 17437847 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548 [TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848 [TBL] [Abstract][Full Text] [Related]
5. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents. Mehar A; Macanas-Pirard P; Mizokami A; Takahashi Y; Kass GE; Coley HM J Pharmacol Exp Ther; 2008 Mar; 324(3):1181-7. PubMed ID: 18089846 [TBL] [Abstract][Full Text] [Related]
6. Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax. Handrick R; Ganswindt U; Faltin H; Goecke B; Daniel PT; Budach W; Belka C; Jendrossek V Radiother Oncol; 2009 Mar; 90(3):413-21. PubMed ID: 19038466 [TBL] [Abstract][Full Text] [Related]
7. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition. Narayanan BA; Narayanan NK; Pttman B; Reddy BS Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [TBL] [Abstract][Full Text] [Related]
9. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth. Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866 [TBL] [Abstract][Full Text] [Related]
10. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Liu B; Shi ZL; Feng J; Tao HM Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
13. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026 [TBL] [Abstract][Full Text] [Related]
15. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955 [TBL] [Abstract][Full Text] [Related]
16. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors. Narayanan NK; Narayanan BA; Reddy BS Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239 [TBL] [Abstract][Full Text] [Related]
18. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib. Jun HJ; Kim YM; Park SY; Park JS; Lee EJ; Choi SA; Pyo H Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):225-34. PubMed ID: 19695440 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model. Inoue T; Anai S; Onishi S; Miyake M; Tanaka N; Hirayama A; Fujimoto K; Hirao Y BMC Urol; 2013 Jan; 13():1. PubMed ID: 23289871 [TBL] [Abstract][Full Text] [Related]
20. [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell]. Wang HJ; Liu XJ; Yang KX; Luo FM; Lou JY; Peng ZL Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):757-60. PubMed ID: 17037745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]